(ELIC) Elicera Therapeutics - Performance 296.2% in 12m
ELIC performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-9.07%
#40 in Peer-Group
Rel. Strength
98.75%
#96 in Stock-Universe
Total Return 12m
296.17%
#3 in Peer-Group
Total Return 5y
-16.61%
#42 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | SEK |
|---|---|
| 52 Week High | 7.38 SEK |
| 52 Week Low | 1.21 SEK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 37.23 |
| Buy/Sell Signal +-5 | 0.48 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ELIC (296.2%) vs XBI (-7.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
10.4% | 76.6% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.77% | -4.62% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
9.62% | 0.48% | 57% | 26.8 | 13.9 | 0.97 | 0.60% | 41% |
| BIM PA Biomerieux |
2.27% | 33.8% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.43% | -8.06% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
13.1% | 44.8% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
0.29% | 36.9% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
8.57% | 17.2% | 11.2% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: ELIC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ELIC
| Total Return (including Dividends) | ELIC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 11.18% | 7.76% | 1.11% |
| 3 Months | 106.80% | -5.31% | 5.58% |
| 12 Months | 296.17% | -7.58% | 10.51% |
| 5 Years | -16.61% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | ELIC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 20.9% | 84.2% | 69.9% |
| 3 Months | 94.8% | -2.8% | 69.3% |
| 12 Months | 79.1% | -77.8% | 43.2% |
| 5 Years | -68.2% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #91 | 3.18% | 9.96% |
| 3 Month | #5 | 118.39% | 95.87% |
| 12 Month | #3 | 328.66% | 258.49% |
| 5 Years | #37 | 35.26% | -44.01% |
FAQs
Does Elicera Therapeutics (ELIC) outperform the market?
Yes,
over the last 12 months ELIC made 296.17%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.58%.
Over the last 3 months ELIC made 106.80%, while XBI made -5.31%.
Performance Comparison ELIC vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ELIC vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -13.1% | 10.1% | 193.1% | 286% |
| US NASDAQ 100 | QQQ | -12.9% | 9.7% | 193.9% | 287% |
| German DAX 40 | DAX | -10.9% | 11.9% | 176.7% | 267% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -12.8% | 12.1% | 191.3% | 285% |
| Hongkong Hang Seng | HSI | -13.6% | 6.1% | 174.1% | 269% |
| India NIFTY 50 | INDA | -11.4% | 12.5% | 194.1% | 298% |
| Brasil Bovespa | EWZ | -15.4% | 10.7% | 172.9% | 287% |
ELIC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -12.8% | 9.7% | 190.3% | 273% |
| Consumer Discretionary | XLY | -12.6% | 13% | 203% | 278% |
| Consumer Staples | XLP | -12.8% | 11.4% | 191.6% | 289% |
| Energy | XLE | -19% | 8.3% | 189.5% | 293% |
| Financial | XLF | -11.5% | 13.8% | 190.3% | 272% |
| Health Care | XLV | -15% | 6.8% | 193.6% | 301% |
| Industrial | XLI | -12.1% | 10.8% | 187.5% | 278% |
| Materials | XLB | -12.4% | 9.8% | 192.3% | 297% |
| Real Estate | XLRE | -13.6% | 10.2% | 192.1% | 283% |
| Technology | XLK | -13.4% | 9.2% | 192.7% | 292% |
| Utilities | XLU | -14.5% | 10.7% | 184.7% | 275% |
| Aerospace & Defense | XAR | -12.1% | 5.4% | 176.2% | 253% |
| Biotech | XBI | -12.8% | 3.4% | 203.9% | 304% |
| Homebuilder | XHB | -11.5% | 16.2% | 208.5% | 306% |
| Retail | XRT | -9.2% | 11.4% | 201% | 295% |
ELIC vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -24.9% | -7.51% | 183% | 293% |
| Natural Gas | UNG | -12.3% | 13.8% | 174.8% | 311% |
| Gold | GLD | -16.7% | 5% | 162.9% | 249% |
| Silver | SLV | -12.3% | -0.2% | 173.5% | 274% |
| Copper | CPER | -10.6% | 9.5% | 178.2% | 288% |
ELIC vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -14.6% | 10.5% | 194.5% | 300% |
| iShares High Yield Corp. Bond | HYG | -13.6% | 10.7% | 189.4% | 287% |